MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

CB Pharma Acquisition Corp Company Profile (NASDAQ:CNLMU)

Consensus Ratings for CB Pharma Acquisition Corp (NASDAQ:CNLMU) (?)
Ratings Breakdown: 3 Hold Rating(s), 16 Buy Rating(s)
Consensus Rating:Buy (Score: 2.84)
Consensus Price Target: $63.18 (510.87% upside)

Analysts' Ratings History for CB Pharma Acquisition Corp (NASDAQ:CNLMU)
Show:
DateFirmActionRatingPrice TargetActions
5/20/2016Telsey Advisory GroupReiterated RatingOutperform$63.00 -> $67.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016WedbushReiterated RatingOutperform$63.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Topeka Capital MarketsReiterated RatingBuy$64.00 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016RBC CapitalReiterated RatingOutperform$68.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Pivotal ResearchReiterated RatingBuy$63.00 -> $64.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016FBR & Co.Reiterated RatingOutperform$66.00 -> $68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Benchmark Co.Reiterated RatingBuy$56.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016NomuraReiterated RatingBuy$60.00 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2016Barrington ResearchReiterated RatingOutperform$61.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2016Deutsche BankReiterated RatingBuy$60.00 -> $64.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2016Needham & Company LLCReiterated RatingBuy$52.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016Stifel NicolausReiterated RatingBuy$54.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016Jefferies GroupReiterated RatingBuy$56.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2016Wells FargoUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016Credit SuisseReiterated RatingOutperform$75.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2016Cowen and CompanyReiterated RatingOutperform$61.00 -> $59.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2015Sanford C. BernsteinReiterated RatingMarket Perform$49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/20/2015BarclaysReiterated RatingEqual Weight$52.00 -> $51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/12/2015Pacific CrestReiterated RatingEqual WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha